Variant report
Variant | nsv972294 |
---|---|
Chromosome Location | chr9:7592837-7603037 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:101)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:7592760-7592910 | GM12878 | blood: | n/a | chr9:7592820-7592828 |
2 | CTCF | chr9:7593080-7593230 | HEK293 | kidney: | n/a | n/a |
3 | CTCF | chr9:7592720-7592870 | HMEC | breast: | n/a | chr9:7592820-7592828 |
4 | CTCF | chr9:7592760-7592910 | AoAF | blood vessel: | n/a | chr9:7592820-7592828 |
5 | CTCF | chr9:7592740-7592890 | SAEC | small airway: | n/a | chr9:7592820-7592828 |
6 | CTCF | chr9:7592800-7592950 | HA-sp | spinal cord: | n/a | chr9:7592820-7592828 |
7 | CTCF | chr9:7593126-7593194 | MCF-7 | breast: | n/a | n/a |
8 | CTCF | chr9:7593040-7593190 | GM12864 | blood: | n/a | n/a |
9 | CTCF | chr9:7592720-7592870 | GM06990 | blood: | n/a | chr9:7592820-7592828 |
10 | CTCF | chr9:7592791-7592856 | LNCaP | prostate: | n/a | chr9:7592820-7592828 |
11 | CTCF | chr9:7592820-7592970 | HUVEC | blood vessel: | n/a | chr9:7592820-7592828 |
12 | CTCF | chr9:7592700-7592850 | GM12875 | blood: | n/a | chr9:7592820-7592828 |
13 | CTCF | chr9:7592760-7592910 | SK-N-SH_RA | brain: | n/a | chr9:7592820-7592828 |
14 | CTCF | chr9:7592760-7592910 | HPF | lung: | n/a | chr9:7592820-7592828 |
15 | CTCF | chr9:7592780-7592930 | NHEK | skin: | n/a | chr9:7592820-7592828 |
16 | CTCF | chr9:7592760-7592910 | MCF-7 | breast: | n/a | chr9:7592820-7592828 |
17 | CTCF | chr9:7592740-7592890 | BE2_C | brain: | n/a | chr9:7592820-7592828 |
18 | CTCF | chr9:7592720-7592870 | GM12870 | blood: | n/a | chr9:7592820-7592828 |
19 | CTCF | chr9:7592742-7592922 | MCF-7 | breast: | n/a | chr9:7592820-7592828 |
20 | CTCF | chr9:7592720-7592870 | HRE | kidney: | n/a | chr9:7592820-7592828 |
21 | CTCF | chr9:7592840-7592990 | HMF | breast: | n/a | n/a |
22 | CTCF | chr9:7592720-7592870 | Caco-2 | colon: | n/a | chr9:7592820-7592828 |
23 | CTCF | chr9:7592760-7592910 | GM12869 | blood: | n/a | chr9:7592820-7592828 |
24 | CTCF | chr9:7592700-7592850 | GM12867 | blood: | n/a | chr9:7592820-7592828 |
25 | CTCF | chr9:7592820-7592970 | HAc | cerebellar: | n/a | chr9:7592820-7592828 |
26 | CTCF | chr9:7592820-7592970 | HMF | breast: | n/a | chr9:7592820-7592828 |
27 | CTCF | chr9:7592760-7592910 | HRPEpiC | eye: | n/a | chr9:7592820-7592828 |
28 | CTCF | chr9:7592676-7593021 | GM12878 | blood: | n/a | chr9:7592820-7592828 |
29 | CTCF | chr9:7592740-7592890 | HCFaa | heart: | n/a | chr9:7592820-7592828 |
30 | CTCF | chr9:7592760-7592910 | HEK293 | kidney: | n/a | chr9:7592820-7592828 |
31 | CTCF | chr9:7592780-7592930 | Caco-2 | colon: | n/a | chr9:7592820-7592828 |
32 | CTCF | chr9:7592700-7592850 | HPAF | blood vessel: | n/a | chr9:7592820-7592828 |
33 | CTCF | chr9:7592740-7592890 | GM12874 | blood: | n/a | chr9:7592820-7592828 |
34 | CTCF | chr9:7592800-7592950 | GM12864 | blood: | n/a | chr9:7592820-7592828 |
35 | CTCF | chr9:7592860-7593010 | GM06990 | blood: | n/a | n/a |
36 | CTCF | chr9:7593160-7593310 | RPTEC | kidney: | n/a | n/a |
37 | CTCF | chr9:7592760-7592910 | GM12873 | blood: | n/a | chr9:7592820-7592828 |
38 | CTCF | chr9:7592780-7592930 | HEK293 | kidney: | n/a | chr9:7592820-7592828 |
39 | CTCF | chr9:7592700-7592850 | AoAF | blood vessel: | n/a | chr9:7592820-7592828 |
40 | CTCF | chr9:7593233-7593250 | MCF-7 | breast: | n/a | n/a |
41 | CTCF | chr9:7592700-7592850 | GM12866 | blood: | n/a | chr9:7592820-7592828 |
42 | CTCF | chr9:7592760-7592910 | HBMEC | blood vessel: | n/a | chr9:7592820-7592828 |
43 | CTCF | chr9:7592780-7592930 | HepG2 | liver: | n/a | chr9:7592820-7592828 |
44 | CTCF | chr9:7592760-7592910 | NHDF-neo | bronchial: | n/a | chr9:7592820-7592828 |
45 | CTCF | chr9:7592780-7592930 | HPF | lung: | n/a | chr9:7592820-7592828 |
46 | CTCF | chr9:7593229-7593281 | MCF-7 | breast: | n/a | n/a |
47 | CTCF | chr9:7592800-7592950 | MCF-7 | breast: | n/a | chr9:7592820-7592828 |
48 | CTCF | chr9:7592780-7592930 | AG04450 | lung: | n/a | chr9:7592820-7592828 |
49 | CTCF | chr9:7592820-7592970 | GM12873 | blood: | n/a | chr9:7592820-7592828 |
50 | CTCF | chr9:7592788-7592908 | HUVEC | blood vessel: | n/a | chr9:7592820-7592828 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000178654 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180929968 | chr9:7592853-7592854 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs540724603 | chr9:7592866-7592867 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs558843416 | chr9:7592869-7592870 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs148213164 | chr9:7592872-7592873 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs117511005 | chr9:7592899-7592900 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs566942447 | chr9:7592920-7592921 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs184896376 | chr9:7592952-7592953 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs140301215 | chr9:7592960-7592961 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs532655814 | chr9:7592964-7592965 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs113082953 | chr9:7592978-7592979 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs541396503 | chr9:7592995-7592996 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs150339860 | chr9:7593040-7593041 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs527358123 | chr9:7593052-7593053 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552293245 | chr9:7593053-7593054 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs138106650 | chr9:7593063-7593064 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs117648800 | chr9:7593064-7593065 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550081848 | chr9:7593086-7593087 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs568325083 | chr9:7593154-7593155 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs373474355 | chr9:7593159-7593160 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs535767741 | chr9:7593165-7593166 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs548242089 | chr9:7593180-7593181 | Flanking Active TSS Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs375621529 | chr9:7593234-7593235 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs543453274 | chr9:7593271-7593272 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs143782527 | chr9:7593274-7593275 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs147213829 | chr9:7593345-7593346 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs561636240 | chr9:7593361-7593362 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs1817573 | chr9:7593375-7593376 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs138308759 | chr9:7593378-7593379 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs1817572 | chr9:7593380-7593381 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs1817571 | chr9:7593391-7593392 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs574745575 | chr9:7593429-7593430 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs537952981 | chr9:7593931-7593932 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs537112671 | chr9:7593960-7593961 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs183373671 | chr9:7594024-7594025 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs574735229 | chr9:7594037-7594038 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs535774082 | chr9:7594042-7594043 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs185769956 | chr9:7594044-7594045 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs148732351 | chr9:7594076-7594077 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs373275370 | chr9:7601600-7601601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186343381 | chr9:7601652-7601653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541181532 | chr9:7601653-7601654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575838454 | chr9:7601654-7601655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564712614 | chr9:7601730-7601731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533402191 | chr9:7601765-7601766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377520680 | chr9:7601794-7601795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543350771 | chr9:7601800-7601801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560697365 | chr9:7601806-7601807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139880360 | chr9:7601811-7601812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs16926462 | chr9:7601812-7601813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs564612652 | chr9:7601815-7601816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:7592400-7593000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr9:7592400-7593200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr9:7592600-7593200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr9:7592600-7593200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr9:7592600-7593200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:7592800-7593200 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr9:7592800-7593200 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
8 | chr9:7593000-7593400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr9:7593000-7593400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr9:7601600-7602200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |